Neumora Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:NMRA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -50.34 M-59.45 M-52.4 M-46.63 M-47.95 M -206.44 M Cash from investing activities -98.8 M44.16 M30.4 M51.32 M42.65 M 168.52 M Cash from financing activities 15.57 M018.46 M-136 K58.77 M 77.09 M Free cash flow -50.34 M-59.45 M-52.4 M-46.63 M-47.95 M -206.44 M

News

Neumora Therapeutics: Downgrading After Navacaprant Development Setback (NASDAQ:NMRA)

Neumora Therapeutics, Inc. (NMRA) Q4 2025 Earnings Call Transcript

Neumora Therapeutics CFO Milligan sells $5119 in shares

Neumora Therapeutics, Inc. (NMRA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Slideshow (NASDAQ:NMRA) 2026-02-12

Intel, Wells Fargo among market cap stock movers on Tuesday

Oracle, Palantir among market cap stock movers on Monday

BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio

Leerink Partners initiates coverage on Neumora stock with Outperform rating

Mizuho reiterates Outperform rating on Neumora Therapeutics stock

Eli Lilly and Regencell among market cap stock movers on Wednesday

Eli Lilly and Intel lead market cap stock movers on Wednesday

Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday - Ascentage Pharma Group (NASDAQ:AAPG), AXT (NASDAQ:AXTI)